ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Carcinogenesis Program Direction Changes Near for Extramural research; Workshop Topics Listed

April 22, 1977

In Brief: House Budget Committee Proposes 5% Cut To NIH In FY96; Steady Reductions Expected

March 24, 1995

NCI Awards $10 Million To States for Cervix Screening

September 27, 1974

Howard Temin, 59, NCAB Member, Nobel Laureate, Dead

February 18, 1994

Grant, contract Awards Held Up By Impasse On Appropriations

October 14, 1977

Monoclonal Antibody Improves AML Response To Therapy

July 26, 2002